Patents by Inventor Kangwen L. Lin

Kangwen L. Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salts of benzimidazolyl pyridyl ethers and formulations thereof
    Patent number: 8501785
    Abstract: Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine. Compositions and formulations including such salts and surfactants as well as methods of preparing such compositions and formulations are provided.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: August 6, 2013
    Assignee: Novartis AG
    Inventors: Rampurna Gullapalli, Ahmad Hashash, Piotr Karpinski, Kangwen L. Lin, Eric M. Loeser, Augustus O. Okhamafe, Paul Allen Sutton, Eduardo Sy
  • SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF
    Publication number: 20120308651
    Abstract: Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine. Compositions and formulations including such salts and surfactants as well as methods of preparing such compositions and formulations are provided.
    Type: Application
    Filed: June 4, 2012
    Publication date: December 6, 2012
    Inventors: Rampurna Gullapalli, Ahmad Hashash, Piotr H. Karpinski, Kangwen L. Lin, Eric M. Loeser, Augustus Okhamafe, Paul Allen Sutton, Eduardo Sy
  • Solid forms of a Raf kinase inhibitor
    Patent number: 8324389
    Abstract: The present invention is directed to solid forms of the Raf kinase inhibitor 1-methyl-5-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine, as well as compositions thereof and uses of the same.
    Type: Grant
    Filed: February 28, 2008
    Date of Patent: December 4, 2012
    Assignee: Novartis AG
    Inventors: Ahmad Hashash, Kangwen L. Lin, Augustus O. Okhamafe
  • Salts of benzimidazolyl pyridyl ethers and formulations thereof
    Patent number: 8202998
    Abstract: Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine. Compositions and formulations including such salts and surfactants as well as methods of preparing such compositions and formulations are provided.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: June 19, 2012
    Assignee: Novartis AG
    Inventors: Rampurna Gullapalli, Ahmad Hashash, Piotr H. Karpinski, Kangwen L. Lin, Eric M. Loeser, Augustus Okhamafe, Paul Allen Sutton, Eduardo Sy
  • Solid Forms of a Raf Kinase Inhibitor
    Publication number: 20100209418
    Abstract: The present invention is directed to solid forms of the Raf kinase inhibitor 1-methyl-5-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine, as well as compositions thereof and uses of the same.
    Type: Application
    Filed: February 28, 2008
    Publication date: August 19, 2010
    Inventors: Ahmad Hashash, Kangwen L. Lin, Augustus O. Okhamafe
  • SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF
    Publication number: 20100168060
    Abstract: Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine. Compositions and formulations including such salts and surfactants as well as methods of preparing such compositions and formulations are provided.
    Type: Application
    Filed: August 30, 2007
    Publication date: July 1, 2010
    Applicant: Novartis AG
    Inventors: Rampurna Gullapalli, Ahmad Hashash, Piotr H. Karpinski, Kangwen L. Lin, Eric M. Loeser, Augustus O. Okhamafe, Paul Allen Sutton, Eduardo Sy